JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Sumit Bose as Non- Executive Independent Director of the company w.e.f. August 31, 2025.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals has re-appointed Mr. Sumit Bose as a Non-Executive Independent Director for a second term of 5 years, effective August 31, 2025, subject to shareholder approval. Mr. Bose is a former Indian Administrative Service officer who served as Union Finance Secretary and Secretary in various key government departments. He also serves on the boards of HDFC Life Insurance, JM Financial, BSE Limited (formerly), and other prominent organisations. He holds a Master's from the London School of Economics and an MA in History from St. Stephen's College, Delhi. The re-appointment is subject to member approval at a general meeting.
This is a routine board re-appointment with no negative implications. Retaining a director of Mr. Bose's stature — a former Union Finance Secretary with experience across top corporates — strengthens the company's governance and independent oversight, which is generally viewed positively by investors.